For benzodiazepines and barbiturates, which of the following statements are true?
A. Both act on GABA
B. Cause additive sedation with alcohol
C. Thiopentone has a short duration of action due to metabolism
D. Flumazenil is an antidote for barbiturates
Appeared in: INI-CET EXAM -2025
Explanation
Both benzodiazepines and barbiturates are CNS depressants that enhance the action of the inhibitory neurotransmitter GABA at the GABA-A receptor.
Benzodiazepines increase the frequency of chloride channel opening, while barbiturates increase the duration of channel opening.
Combining these drugs with other CNS depressants like alcohol leads to a dangerous additive sedative effect, significantly increasing the risk of respiratory depression and death.
Why Other Options Were Wrong
Option B: This option is incorrect because it omits statement B, which is also true. Both benzodiazepines and barbiturates cause additive sedation with alcohol, a critical clinical fact.
Option C: This option is incorrect because statement C is false. The short duration of action of Thiopentone is due to redistribution from the brain to other tissues, not primarily due to metabolism.
Option D: This option is incorrect because statements C and D are false. Thiopentone's action is terminated by redistribution, and Flumazenil is an antidote for benzodiazepines, not barbiturates.
Related Visual
Visual 1: Diagram - A diagram of the GABA-A receptor showing the distinct binding sites for GABA, benzodiazepines, barbiturates, and alcohol. This helps visualize why their effects are related but distinct.
Visual 2: Flowchart - A flowchart illustrating the mechanism of action for both drug classes, showing how they both lead to increased chloride influx and neuronal inhibition.
Visual 3: Table - A comparison table of Benzodiazepines vs. Barbiturates, highlighting their mechanism, antidote, therapeutic index, and risk of dependence and overdose.
Clinical Relevance
Nursing practice connection: This is primarily an exam-oriented knowledge point with limited direct bedside application, so retain Pharmacological properties of Benzodiazepines and Barbiturates as background academic context rather than a clinical decision trigger.
A core nursing responsibility is patient education on medication safety. Nurses must warn patients prescribed benzodiazepines or barbiturates about the life-threatening danger of consuming alcohol or other CNS depressants concurrently.
In an overdose situation, recognizing the substance is critical. If a patient presents with CNS depression, knowing that Flumazenil is effective for benzodiazepines but not for barbiturates guides emergency treatment. For barbiturate overdose, the focus is on supportive care like mechanical ventilation.
What if? If a patient on long-term diazepam for anxiety also drinks alcohol daily, the nurse must identify this as a high-risk situation. The priority nursing action would be to educate the patient on the severe risks and report the concurrent use to the prescribing physician for a potential medication review and substance use counseling.
How to Approach the Question
First, break down the question into its four component statements (A, B, C, D).
Evaluate each statement individually based on your pharmacology knowledge.
Statement A: Recall the mechanism of action for sedative-hypnotics. Both BZDs and barbiturates are known to target the GABA system. This is true.
Statement B: Consider drug interactions. Both are CNS depressants, as is alcohol. Combining them will have an additive effect. This is true.
Statement C: Analyze the pharmacokinetics. Thiopentone is a classic example of a drug whose action is terminated by redistribution, not metabolism. The reason given is incorrect. This is false.
Statement D: Recall specific antidotes. Flumazenil is the specific antidote for benzodiazepines. There is no specific antidote for barbiturates. This is false.
Concept Tested & Keywords
Concept Tested: Pharmacological properties of Benzodiazepines and Barbiturates